Analysts Set Expectations for Iovance Biotherapeutics, Inc.'s FY2023 Earnings (NASDAQ:IOVA)

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) – Research analysts at HC Wainwright lifted their FY2023 EPS estimates for shares of Iovance Biotherapeutics in a research note issued on Wednesday, November 8th. HC Wainwright analyst J. Pantginis now expects that the biotechnology company will post earnings of ($1.90) per share for the year, up from […]

Related Keywords

United States ,American ,Iovance Biotherapeutic ,Iovance Biotherapeutics ,Merrilla Mcpeak ,Waynep Rothbaum ,Robertw Baird ,Nasdaq ,Securities Exchange Commission ,Baird Financial Group Inc ,American Century Companies Inc ,Lazard Asset Management ,Macquarie Group Ltd ,Iovance Biotherapeutics Inc ,Free Report ,Get Free Report ,Director Merrill ,Director Wayne ,Exchange Commission ,Asset Management ,Financial Group ,Century Companies ,Macquarie Group ,Nasdaq Iova ,Tiova ,Medical ,Earnings Estimates ,Hc Wainwright ,